Spinal Cord Stimulation Devices Market

Valued at approximately $2.5bn in 2017, the Spinal Cord Stimulation (SCS) Devices Market is one of the largest neuromodulation segments and one of the fastest-growing medical device markets today. The market is expanding at double-digits due to the strong demand for safe and effective, sustainable therapies for treating chronic, debilitating, intractable pain of the trunk and/or limbs (eg, excruciating back or leg pain) in carefully selected patients.

SCS devices have the capacity to provide an average 50% or greater reduction in chronic pain, and the market is presently undergoing a significant technological revolution, supported by increased awareness and a strong and growing surgeon network, all of which is expected to improve therapy and drive market growth in the decades to come. Overall, the SCS market is truly an exciting medical device market due to fast-paced innovation and the ability to help alleviate chronic pain and suffering among a growing population of desperate patients who can no rely on highly addictive pain medications. Future technologies may provide even greater pain relief (approaching an 80% reduction in pain or more), involve miniaturized, customized, automatic "closed loop" therapy, and other innovative features that may one day dramatically reduce the sensation of excruciating pain and eliminate the need for surgery, or the implantation of the implantable pulse generators, altogether.

This report provides the following useful information:

• chronic pain overview and pain prevalence data
• product portfolios offered by leading manufacturers
• proprietary/innovative SCS device features
• major clinical trial data
• key technological trends
• primary research
• startups and innovative emerging technologies impacting the market
• in-depth market and competitive analyses (including 5-year market forecast and 2017 market share by region) 

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.